Feng Zhu
- Cancer Research top 5%
- Molecular Biology top 2%
- Cell death mechanisms and regulation 16
- FOXO transcription factor regulation 14
- Melanoma and MAPK Pathways 9
- Genomics, phytochemicals, and oxidative stress 7
- PI3K/AKT/mTOR signaling in cancer 7
- Biochemistry top 2%
- Toxicology top 2%
-
- Cancer-related Molecular Pathways 18
-
- Cancer Mechanisms and Therapy 8
-
- Skin Protection and Aging 7
Feng Zhu
118 papers receiving 4.1k citations
Peers
Comparison fields: 5 of 130
- Cancer Research 639
- Applied Microbiology and Biotechnology 77
- Molecular Biology 2.6k
- Biochemistry 221
- Toxicology 109
Countries citing papers authored by Feng Zhu
This map shows the geographic impact of Feng Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Zhu more than expected).
Fields of papers citing papers by Feng Zhu
This network shows the impact of papers produced by Feng Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Zhu. The network helps show where Feng Zhu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Feng Zhu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2023 | 5 | |
| 3 | 2023 | 2 | |
| 4 | 2022 | 12 | |
| 5 | 2021 | 25 | |
| 6 | 2020 | 2 | |
| 7 | 2020 | 21 | |
| 8 | 2018 | 15 | |
| 9 | 2014 | 47 | |
| 10 | 2013 | 91 | |
| 11 | 2013 | 4 | |
| 12 | 2012 | 26 | |
| 13 | 2011 | 33 | |
| 14 | 2010 | 25 | |
| 15 | 2010 | 45 | |
| 16 | 2010 | 69 | |
| 17 | 2009 | 74 | |
| 18 | 2008 | 54 | |
| 19 | TOPK phosphorylation of histone H2AX prevents arsenite-induced apoptosis in RPMI7951 melanoma cells | 2008 | 1 |
| 20 | 2004 | 34 |
About Feng Zhu
Feng Zhu is a scholar working on Oncology, Cancer Research and Molecular Biology, having authored 122 papers that have together received 4.1k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (18 papers), Cell death mechanisms and regulation (16 papers), FOXO transcription factor regulation (14 papers), Melanoma and MAPK Pathways (9 papers), Cancer Mechanisms and Therapy (8 papers), Genomics, phytochemicals, and oxidative stress (7 papers), PI3K/AKT/mTOR signaling in cancer (7 papers) and Skin Protection and Aging (7 papers). The work is most often cited by research in Cancer Research (639 citations), Applied Microbiology and Biotechnology (77 citations) and Molecular Biology (2.6k citations). Feng Zhu has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Ann M. Bode, Zigang Dong, Yong‐Yeon Cho, Weiya Ma, Tatyana A. Zykova, Cong Peng, Chengrong Lu, Faqing Tang, Ke Yao and Duo Zheng. Their work appears in journals such as Journal of Biological Chemistry, Molecular Cell and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.